Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: Clin Cancer Res. 2015 Oct 12;22(4):868–876. doi: 10.1158/1078-0432.CCR-15-0481

Table 2.

Baseline relative MDM2 gene expression by best hematological response in the blood of AML patients

CR
(N = 3)
CRp
(N = 2)
PR
(N = 3)
SD
(N = 21)
PD
(N = 40)
MS
(N = 15)
Overall
(N = 84)
n 2 1 2 10 17 9 41
Mean 1.66 0.73 0.75 0.8 0.54 0.64 0.7

CR, complete response; CRp, complete response without full platelet recovery; PR, partial response; SD, stable disease; PD, progressive disease; MS, missing or assessment not done; MDM2, murine double mutant 2; AML, acute myelogenous leukemia